STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells

Abstract In this study, we aimed to evaluate the cytotoxic and apoptotic effects of zoledronic acid on K562 chronic myeloid leukemia (CML) cells and to examine the roles of STAT genes on zoledronic acid-induced apoptosis. The results showed that zoledronic acid decreased proliferation, and induced a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedicine & pharmacotherapy 2013-07, Vol.67 (6), p.527-532
Hauptverfasser: Kiper, Hatice Demet, Tezcanli Kaymaz, Burcin, Gokbulut, Aysun Adan, Selvi, Nur, Avci, Cigir Biray, Kosova, Buket, Iskender, Guniz, Yandim, Melis Kartal, Gunduz, Cumhur, Sahin, Fahri, Baran, Yusuf, Saydam, Guray
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract In this study, we aimed to evaluate the cytotoxic and apoptotic effects of zoledronic acid on K562 chronic myeloid leukemia (CML) cells and to examine the roles of STAT genes on zoledronic acid-induced apoptosis. The results showed that zoledronic acid decreased proliferation, and induced apoptosis in K562 cells in a dose- and time-dependent manner. mRNA and protein levels of STAT3 , -5A and -5B genes were significantly reduced in zoledronic acid-treated K562 cells. These data indicated that STAT inhibition by zoledronic acid may be therapeutic in CML patients following the confirmation with clinical studies.
ISSN:0753-3322
1950-6007
DOI:10.1016/j.biopha.2013.04.006